Clinical Trial Update: Hematopoietic Stem Cell Support in Patients With Autoimmune Bullous Skin Disorders [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating hematopoietic stem cell support in patients with pemphigus, an autoimmune bullous skin disorder, has terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pemphigus

Snippet

Sponsor: Richard Burt, MD | Conditions: Pemphigus | Phase 1 | Status: TERMINATED